CD133, a surface marker of normal human neural precursors, is used to isolate CSCs from primary brain tumor cells and other cancer cells, such as melanoma, osteosarcoma, hepatoma, colorectal cancer, gastric cancer, and breast cancer cells [40,57]. This evidence concerns the gene PROM1 and cancer.